Ibx Group Stock Net Income
Fundamental analysis of IBX allows traders to better anticipate movements in IBX's stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -3.2 M | -3.1 M | |
| Net Loss | -3.2 M | -3.1 M | |
| Net Loss | -3.2 M | -3.1 M |
IBX | Net Income | Build AI portfolio with IBX Stock |
iBX Group Company Net Income Analysis
IBX's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current IBX Net Income | (3.6 M) |
Most of IBX's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iBX Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
IBX Operating Income
Operating Income |
|
Based on the recorded statements, iBX Group reported net income of (3.6 Million). This is 100.67% lower than that of the Technology sector and 108.56% lower than that of the Health Information Services industry. The net income for all United States stocks is 100.63% higher than that of the company.
IBX Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IBX's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IBX could also be used in its relative valuation, which is a method of valuing IBX by comparing valuation metrics of similar companies.IBX is currently under evaluation in net income category among its peers.
IBX Fundamentals
| Return On Asset | -2.08 | ||||
| Operating Margin | (3.63) % | ||||
| Current Valuation | 1.49 M | ||||
| Shares Outstanding | 197.48 M | ||||
| Price To Sales | 0 X | ||||
| Revenue | 3.33 M | ||||
| Gross Profit | (1.48 M) | ||||
| EBITDA | (5.08 M) | ||||
| Net Income | (3.6 M) | ||||
| Cash And Equivalents | 16.99 K | ||||
| Total Debt | 132.29 K | ||||
| Current Ratio | 0.18 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (2.47 M) | ||||
| Earnings Per Share | (0.07) X | ||||
| Number Of Employees | 47 | ||||
| Beta | 124.64 | ||||
| Market Capitalization | 1.97 K | ||||
| Total Asset | 1.5 M | ||||
| Retained Earnings | (6.41 M) | ||||
| Working Capital | (3.6 M) | ||||
| Current Asset | 782 K | ||||
| Current Liabilities | 4.38 M | ||||
| Net Asset | 1.5 M |
About IBX Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iBX Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IBX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iBX Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out IBX Piotroski F Score and IBX Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Medical Care Facilities space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IBX. If investors know IBX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IBX listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.07) | Revenue Per Share 0.008 | Quarterly Revenue Growth (0.62) | Return On Assets (2.08) |
The market value of iBX Group is measured differently than its book value, which is the value of IBX that is recorded on the company's balance sheet. Investors also form their own opinion of IBX's value that differs from its market value or its book value, called intrinsic value, which is IBX's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IBX's market value can be influenced by many factors that don't directly affect IBX's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IBX's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.